Exhibit 4.4
FORM OF WARRANT AGREEMENT
DMY SQUARED TECHNOLOGY GROUP, INC.
and
CONTINENTAL STOCK TRANSFER & TRUST COMPANY
Dated , 2022
THIS WARRANT AGREEMENT (this “Agreement”), dated , 2022, is by and between dMY Squared Technology Group, Inc., a Massachusetts corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”).
WHEREAS, it is proposed that the Company enter into that certain Private Placement Warrants Purchase Agreement, with dMY Squared Sponsor, LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which the Sponsor will purchase an aggregate of 3,050,000 warrants (or up to 3,207,500 warrants if the underwriters in the Public Offering (defined below) exercise their Over-allotment Option (as defined below) in full) simultaneously with the closing of the Offering (and the closing of the Over-allotment Option, if applicable), bearing the legend set forth in Exhibit B hereto (the “Private Placement Warrants”) at a purchase price of $1.00 per Private Placement Warrant. Each Private Placement Warrant entitles the holder thereof to purchase one share of Class A Common Stock (as defined below) at a price of $11.50 per share, subject to adjustment as described herein; and
WHEREAS, in order to finance the Company’s transaction costs in connection with an intended initial merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination, involving the Company and one or more businesses (a “Business Combination”), the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as the Company may require, of which up to $1,500,000 of such loans may be convertible into up to an additional 1,500,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant; and
WHEREAS, in order to extend the period of time the Company has to consummate a Business Combination by an additional three-month period, the Sponsor or its affiliates or designees must deposit into the trust account additional funds of $750,000, or $862,500 if the underwriter’s Over-allotment Option is exercised in full ($0.10 per Unit in either case), for each of the available three-month extensions, for a total payment of up to $1,500,000, or $1,725,000 if the underwriter’s Over-allotment Option is exercised in full ($0.20 per Unit in either case), in exchange for a non-interest bearing, unsecured promissory note, and such loan may be convertible into warrants, bearing the legend set forth in Exhibit B hereto, at a price of $1.00 per warrant at the option of the lender, which will be identical to the Private Placement Warrants (the “Extension Warrants”);
WHEREAS, the Company is engaged in an initial public offering (the “Offering”) of units of the Company’s equity securities, each such unit comprised of one share of Class A common stock of the Company, par value $0.0001 per share (“Common Stock”), and one-half of one Public Warrant (as defined below) (the “Units”) and, in connection therewith, has determined to issue and deliver up to 3,750,000 redeemable warrants (including up to 4,312,500 redeemable warrants subject to the Over-allotment Option) to public investors in the Offering (the “Public Warrants” and, together with the Private Placement Warrants and the Extension Warrants, the “Warrants”). Each whole Warrant entitles the holder thereof to purchase one share of Common Stock for $11.50 per share, subject to adjustment as described herein. Only whole Warrants are exercisable. A holder of the Public Warrants will not be able to exercise any fraction of a Warrant; and